Caitlin John, LLC Merck & Co., Inc. Transaction History
Caitlin John, LLC
- $110 Billion
- Q2 2025
A detailed history of Caitlin John, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Caitlin John, LLC holds 3,951 shares of MRK stock, worth $317,265. This represents 0.28% of its overall portfolio holdings.
Number of Shares
3,951
Previous 3,301
19.69%
Holding current value
$317,265
Previous $296 Million
5.56%
% of portfolio
0.28%
Previous 0.29%
Shares
7 transactions
Others Institutions Holding MRK
# of Institutions
3,834Shares Held
1.96BCall Options Held
27.4MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.52 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.17 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.73 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $203B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...